Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Garetosmab

COURAGE

Regeneron · Phase 2 · Active, not recruiting · Enrollment 1005

NCT06299098

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebon/rn/rn/rn/rn/r
Trevogrumabn/rn/rn/rn/rn/r
Arm A0n/rn/rn/rn/rn/r
Arm A1n/rn/rn/rn/rn/r
Arm B0n/rn/rn/rn/rn/r
Arm B1n/rn/rn/rn/rn/r
Arm C0n/rn/rn/rn/rn/r
Arm C1n/rn/rn/rn/rn/r
Arm D0n/rn/rn/rn/rn/r
Arm D1n/rn/rn/rn/rn/r
Arm 1n/rn/rn/rn/rn/r
Arm 2n/rn/rn/rn/rn/r
Arm 3n/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.